These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
270 related articles for article (PubMed ID: 27227130)
41. Increasing the number of adverse drug reactions reporting: the role of clinical pharmacy residents. Baniasadi S; Habibi M; Haghgoo R; Karimi Gamishan M; Dabaghzadeh F; Farasatinasab M; Farsaei S; Gharekhani A; Kafi H; Karimzadeh I; Kharazmkia A; Najmeddin F; Nikvarz N; Oghazian MB; Rezaee H; Sadeghi K; Tafazzoli A; Shahsavari N; Fahimi F Iran J Pharm Res; 2014; 13(1):291-7. PubMed ID: 24734083 [TBL] [Abstract][Full Text] [Related]
42. Drug safety reports on complementary and alternative medicines (ayurvedic and homeopathic medicines) by a spontaneous reporting program in a tertiary care hospital. Jose J; Rao PG; Kamath MS; Jimmy B J Altern Complement Med; 2009 Jul; 15(7):793-7. PubMed ID: 19534607 [TBL] [Abstract][Full Text] [Related]
43. A small economic inducement to stimulate increased reporting of adverse drug reactions--a way of dealing with an old problem? Bäckström M; Mjörndal T Eur J Clin Pharmacol; 2006 May; 62(5):381-5. PubMed ID: 16572320 [TBL] [Abstract][Full Text] [Related]
44. Experiences with adverse drug reaction reporting by patients: an 11-country survey. van Hunsel F; Härmark L; Pal S; Olsson S; van Grootheest K Drug Saf; 2012 Jan; 35(1):45-60. PubMed ID: 22149419 [TBL] [Abstract][Full Text] [Related]
45. An observational study to compare the contents and quality of information furnished in CDSCO ADR reporting form, yellow card, medwatch and blue form by the healthcare professionals. Rehan HS; Chopra D; Holani SN; Mishra R Int J Risk Saf Med; 2014; 26(1):1-8. PubMed ID: 24796346 [TBL] [Abstract][Full Text] [Related]
46. Adverse drug reaction monitoring in a secondary care hospital in South India. Arulmani R; Rajendran SD; Suresh B Br J Clin Pharmacol; 2008 Feb; 65(2):210-6. PubMed ID: 17662089 [TBL] [Abstract][Full Text] [Related]
47. Qualitative Study of General Public Views towards Adverse Drug Reactions in Lithuania. Valinciute-Jankauskiene A; Loreta K Healthcare (Basel); 2021 Mar; 9(3):. PubMed ID: 33803215 [TBL] [Abstract][Full Text] [Related]
48. Adverse drug reactions in a south Indian hospital--their severity and cost involved. Ramesh M; Pandit J; Parthasarathi G Pharmacoepidemiol Drug Saf; 2003 Dec; 12(8):687-92. PubMed ID: 14762985 [TBL] [Abstract][Full Text] [Related]
49. Adverse drug reaction monitoring: comparing doctor and patient reporting for new drugs. Jarernsiripornkul N; Kakaew W; Loalukkana W; Krska J Pharmacoepidemiol Drug Saf; 2009 Mar; 18(3):240-5. PubMed ID: 19148880 [TBL] [Abstract][Full Text] [Related]
50. A cross-sectional study of surveillance of adverse drug reactions in inpatient departments of a tertiary care hospital. Remesh A; Balan A; Gnanadurai A J Basic Clin Physiol Pharmacol; 2014 Feb; 25(1):125-30. PubMed ID: 24423467 [TBL] [Abstract][Full Text] [Related]
51. Implementation of a peer support intervention to promote the detection, reporting and management of adverse drug reactions in people living with HIV in Uganda: a protocol for a quasi-experimental study. Kiguba R; Ndagije HB; Nambasa V; Katureebe C; Zakumumpa H; Nanyonga SM; Ssanyu JN; Tregunno P; Harrison K; Merle CS; Raguenaud ME; Kitutu FE BMJ Open; 2022 May; 12(5):e056039. PubMed ID: 35589351 [TBL] [Abstract][Full Text] [Related]
52. Educational intervention to improve physician reporting of adverse drug reactions (ADRs) in a primary care setting in complementary and alternative medicine. Tabali M; Jeschke E; Bockelbrink A; Witt CM; Willich SN; Ostermann T; Matthes H BMC Public Health; 2009 Jul; 9():274. PubMed ID: 19643033 [TBL] [Abstract][Full Text] [Related]
53. Bias in spontaneous reporting of adverse drug reactions in Japan. Matsuda S; Aoki K; Kawamata T; Kimotsuki T; Kobayashi T; Kuriki H; Nakayama T; Okugawa S; Sugimura Y; Tomita M; Takahashi Y PLoS One; 2015; 10(5):e0126413. PubMed ID: 25933226 [TBL] [Abstract][Full Text] [Related]
54. Knowledge, attitude and practices toward pharmacovigilance and adverse drug reactions in postgraduate students of Tertiary Care Hospital in Gujarat. Upadhyaya HB; Vora MB; Nagar JG; Patel PB J Adv Pharm Technol Res; 2015; 6(1):29-34. PubMed ID: 25709967 [TBL] [Abstract][Full Text] [Related]
55. Attitudinal survey of voluntary reporting of adverse drug reactions. Eland IA; Belton KJ; van Grootheest AC; Meiners AP; Rawlins MD; Stricker BH Br J Clin Pharmacol; 1999 Oct; 48(4):623-7. PubMed ID: 10583035 [TBL] [Abstract][Full Text] [Related]
56. Educational intervention to improve knowledge, attitude, and practice of pharmacovigilance among resident doctors at a tertiary care hospital. Hingorani SK; Shah AY; Mehta CD Perspect Clin Res; 2023; 14(2):75-80. PubMed ID: 37325579 [TBL] [Abstract][Full Text] [Related]
57. Program coordinated by a drug information service to improve adverse drug reaction reporting in a hospital. Michel DJ; Knodel LC Am J Hosp Pharm; 1986 Sep; 43(9):2202-5. PubMed ID: 3766573 [TBL] [Abstract][Full Text] [Related]
58. The influence of primary care prescribing rates for new drugs on spontaneous reporting of adverse drug reactions. Clark RC; Maxwell SR; Kerr S; Cuthbert M; Buchanan D; Steinke D; Webb DJ; Bateman ND Drug Saf; 2007; 30(4):357-66. PubMed ID: 17408312 [TBL] [Abstract][Full Text] [Related]
59. Important information regarding reporting of adverse drug reactions: a qualitative study. Rolfes L; Wilkes S; van Hunsel F; van Puijenbroek E; van Grootheest K Int J Pharm Pract; 2014 Jun; 22(3):231-3. PubMed ID: 23937120 [TBL] [Abstract][Full Text] [Related]
60. A Retrospective Analysis of Reporting of Adverse Drug Reactions in a Tertiary Care Teaching Hospital: One Year Survey. Pathak AK; Kumar M; Dokania S; Mohan L; Dikshit H J Clin Diagn Res; 2016 Aug; 10(8):FC01-4. PubMed ID: 27656459 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]